Outcome in Patients Having Salvage Coronary Artery Bypass Grafting

Giuseppe Santarpino1, Vito G Ruggieri2, Giovanni Mariscalco3

  • 1Department of Cardiac Surgery, Paracelsus Medical University Nuremberg, Nuremberg, Germany.

Insights

Salvage coronary artery bypass grafting (CABG) in critically ill patients carries high mortality and complication risks. However, outcomes suggest it may be justified in select cases, with extracorporeal membrane oxygenation (ECMO) showing encouraging results.

Area of Science:

  • Cardiovascular Surgery
  • Critical Care Medicine
  • Interventional Cardiology

Background:

  • Salvage coronary artery bypass grafting (CABG) is an aggressive approach for cardiogenic shock, often performed without robust clinical justification.
  • The clinical data supporting salvage CABG in critically ill patients remains limited.

Purpose of the Study:

  • To analyze the early and intermediate outcomes of salvage CABG in patients with cardiogenic shock.
  • To evaluate the impact of extracorporeal membrane oxygenation (ECMO) on outcomes in this patient population.

Main Methods:

  • Retrospective review of 85 patients undergoing salvage CABG across 11 European cardiac surgery centers.
  • Definition of salvage CABG based on EuroSCORE criteria (requiring cardiopulmonary resuscitation before or during anesthesia).
  • Analysis of in-hospital mortality, postoperative complications, and long-term survival, including subgroup analysis for ECMO patients.

Main Results:

  • In-hospital mortality was high at 35.3%, with a mean EuroSCORE II of 32.0%.
  • Significant postoperative complications included stroke (9.4%), resternotomy (38.8%), dialysis (18.8%), gastrointestinal issues (12.9%), and deep sternal wound infection (10.6%).
  • One, three, and five-year survival rates were 58.6%, 49.8%, and 40.9%, respectively. Patients treated with ECMO had particularly high complication rates and lower survival (29.2% at 1 year).

Conclusions:

  • Salvage CABG is associated with substantial immediate mortality and severe adverse events in critically ill patients.
  • Despite the risks, the observed outcomes may justify the procedure in carefully selected patients.
  • Extracorporeal membrane oxygenation (ECMO) support in these patients, while associated with high risks, shows encouraging survival rates and warrants further investigation.

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
585
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
432
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
418